VIKING GLOBAL INVESTORS LP
Institutional investor · Portfolio as of Q4 2022
Top Holdings76 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
VISA INC-CLASS A SHARES | 5.8M | $1.2B | 6.0% | $190.31 | +6.09% | 17 qtrssince 2018-Q4 | Increased 67 |
AMAZON.COM INC | 12.5M | $1B | 5.2% | $104.62 | -19.71% | 17 qtrssince 2018-Q4 | Increased 80 |
ANTHEM INC | 1.9M | $960.4M | 4.8% | $452.82 | +8.27% | 4 qtrssince 2022-Q1 | Decreased 0 |
MCKESSON CORP | 2.2M | $826.9M | 4.1% | $327.70 | +12.80% | 3 qtrssince 2022-Q2 | Decreased 0 |
MICROSOFT CORP | 3.4M | $822.4M | 4.1% | $202.60 | +15.61% | 17 qtrssince 2018-Q4 | Decreased 0 |
CHUBB LTD | 3.6M | $789.8M | 4.0% | $143.86 | +46.93% | 12 qtrssince 2020-Q1 | Decreased 0 |
ROIVANT SCIENCES LTD | 88.2M | $705M | 3.5% | $10.64 | -24.91% | 5 qtrssince 2021-Q4 | Unchanged 0 |
UNITEDHEALTH GROUP INC | 1.3M | $672.1M | 3.4% | $495.94 | +1.20% | 2 qtrssince 2022-Q3 | Increased 94 |
GENERAL ELECTRIC CO COM STOCK | 7.8M | $651.5M | 3.3% | $53.32 | -3.58% | 9 qtrssince 2020-Q4 | Decreased 0 |
API GROUP CORP | 33.8M | $636.1M | 3.2% | $8.14 | +54.12% | 11 qtrssince 2020-Q2 | Unchanged 0 |
MASTERCARD INC - A | 1.7M | $594.3M | 3.0% | $345.33 | -1.21% | 4 qtrssince 2022-Q1 | Decreased 0 |
HDFC BANK LTD-ADR | 8.6M | $586.3M | 2.9% | $29.56 | +10.65% | 6 qtrssince 2021-Q3 | Decreased 0 |
BIOMARIN PHARMACEUTICAL INC | 5.3M | $545.8M | 2.7% | $86.38 | +19.81% | 5 qtrssince 2021-Q4 | Increased 56 |
AMERIPRISE FINANCIAL INC | 1.6M | $513.1M | 2.6% | $228.64 | +29.24% | 8 qtrssince 2021-Q1 | Decreased 0 |
CSX CORP | 15.5M | $481.7M | 2.4% | $29.66 | 0.00% | 1 qtr | New 81 |
THERMO FISHER SCIENTIFIC INC | 839,526 | $462.3M | 2.3% | $538.57 | +1.34% | 11 qtrssince 2020-Q2 | Increased 72 |
INTUIT INC | 1.2M | $459.9M | 2.3% | $380.25 | +0.17% | 3 qtrssince 2022-Q2 | Increased 55 |
BOSTON SCIENTIFIC CORP | 9.5M | $440.9M | 2.2% | $40.33 | +14.72% | 17 qtrssince 2018-Q4 | Decreased 0 |
MICRON TECHNOLOGY INC | 8.4M | $417.8M | 2.1% | $50.16 | -1.80% | 3 qtrssince 2022-Q2 | Increased 75 |
ROYALTY PHARMA PLC- CL A | 10M | $395.5M | 2.0% | $37.54 | -2.92% | 11 qtrssince 2020-Q2 | Decreased 0 |
VIKING GLOBAL INVESTORS LP manages $20B across 76 positions as of Q4 2022. Top holdings: V (6.0%), AMZN (5.2%), ELV (4.8%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2.5/5.0.
Active quarter - 14 new positions, 26 exits, 21 increased. Top move: UNH (INCREASED, conviction 94). Portfolio: $20.0B across 76 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer